Settlement Planning in the Yaz Litigation
Since the class action settled in 2013, Milestone has assisted with the settlements of over 8,000 lawsuits against Bayer Healthcare Pharmaceuticals Inc. with respect to Yaz Birth Control. The lawsuits alleged that the drug maker failed to adequately warn consumers and the medical community about the potential risk of Yaz side effects. Thousands of women who took the drug now suffer from deep vein thrombosis (blood clots), pulmonary embolism, and/or strokes.
Bayer had sole access to facts concerning the potential hazards of Yaz and ignored the connection between its drug and potentially life-threatening side effects. In turn, the drug maker’s profits increased at the expense of women who took the medication, some of whom have been affected by serious complications and injuries, including life-threatening conditions.
Bayer was ordered to pay out over $1.4 billion in Yaz lawsuit settlements.
As a lifelong advocate of the civil justice system, Milestone Consulting has assisted numerous mass tort firms by providing settlement planning advice to their clients. Milestone also provided individual consultation to those claimants, educating them on how the acceptance of a settlement may affect them, and how to best use the funding to the greatest advantage. Our company has extensive experience regarding settlement planning and has assisted thousands of claimants in the following areas:
- Government Benefit Preservation
- Needs-Based Financial Planning
- Pooled and Special Needs Trusts
- College Planning and Financial Aid
- Tax-Exempt Structured Settlements
Milestone prides itself on being an advocate for women, as well as a supporter for the Davids going up against Goliaths in this country. Our work with plaintiffs from the Yaz settlement has helped them move beyond their lawsuit against Bayer and onto the next step of a secure financial future tailored to their healthcare needs and their lifetime goals.